What is prescription price transparency? Learn about its impact on medication adherence, medication abandonment, treatment delays, pharmacy call-backs, and sticker shock.
Content will illuminate the concept of prescription price transparency and its impact on the patient journey experience from provider-to-prescriber-to-patient-to-pharmacist-to-patient.
Luke manages the Electronic Prior Authorization product portfolio on the Surescripts Product Innovation and Strategy team. He has extensive experience developing, managing, and supporting healthcare IT products. He is also actively involved in the NCPDP electronic Prior Authorization (ePA) task group. Luke has a BA from the University of Northern Iowa and an MA from the University of Minnesota.